MD3244G2 - Metodă de apreciere a agresivităţii cancerului endometrial - Google Patents
Metodă de apreciere a agresivităţii cancerului endometrialInfo
- Publication number
- MD3244G2 MD3244G2 MDA20060139A MD20060139A MD3244G2 MD 3244 G2 MD3244 G2 MD 3244G2 MD A20060139 A MDA20060139 A MD A20060139A MD 20060139 A MD20060139 A MD 20060139A MD 3244 G2 MD3244 G2 MD 3244G2
- Authority
- MD
- Moldova
- Prior art keywords
- aggressivity
- endometrial cancer
- units
- determined
- determining
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la medicină, în special la oncologie şi poate fi utilizată pentru aprecierea precoce neinvazivă a agresivităţii cancerului endometrial.Esenţa invenţiei constă în aceea că se determină în ţesuturile endometrial şi miometrial nivelul de ARN mesager pentru triptofanhidroxilaza-1, şi în cazul, în care nivelul constituie 0…15 unităţi se determină o agresivitate majoră, 16…400 unităţi - o agresivitate medie, 400 unităţi şi mai mult se determină o agresivitate scăzută a cancerului endometrial.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060139A MD3244G2 (ro) | 2006-05-15 | 2006-05-15 | Metodă de apreciere a agresivităţii cancerului endometrial |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060139A MD3244G2 (ro) | 2006-05-15 | 2006-05-15 | Metodă de apreciere a agresivităţii cancerului endometrial |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3244F1 MD3244F1 (ro) | 2007-02-28 |
MD3244G2 true MD3244G2 (ro) | 2007-12-31 |
Family
ID=37845198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20060139A MD3244G2 (ro) | 2006-05-15 | 2006-05-15 | Metodă de apreciere a agresivităţii cancerului endometrial |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3244G2 (ro) |
-
2006
- 2006-05-15 MD MDA20060139A patent/MD3244G2/ro not_active IP Right Cessation
Non-Patent Citations (10)
Title |
---|
<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Chen+G%22%5BAuthor%5D>., Zhang B * |
<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Zhang+B%22%5BAuthor%5D>. Expression of vascular * |
endothelial growth factor and its receptors in endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi. <javascript:AL_get(this,%20'jour',%20'Zhonghua%20Bing%20Li% * |
for clinical gynecological disease. Gynecol. Obstet. Invest., 1990, № 29, p. 214 * |
H <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Wang+H%22%5BAuthor%5D>., Chen G * |
I., Bast R. The CA125 tumour-associated antigen: a review of the literature. * |
Iwanari O., Miyako J., Date Y., Nakayama S., Kijima S., Moriyama M., Karino K., Endoh J., Kitao M. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease. Gynecol. Obstet. Invest., 1990, № 29, p. 214 * |
Jacobs I., Bast R. The CA125 tumour-associated antigen: a review of the literature. * |
O., Miyako J., Date Y., Nakayama S., Kijima S., Moriyama M., Karino K., Endoh J., Kitao M. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen * |
Wang H., Chen G., Zhang B. Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi. 2002, № 31, p. 391-395 * |
Also Published As
Publication number | Publication date |
---|---|
MD3244F1 (ro) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1133680A1 (en) | Nucleic acid enzymes and complexes and methods for their use | |
WO2005005462A3 (en) | Blys antagonists and uses thereof | |
WO2007013950A3 (en) | Combination therapy of her expressing tumors | |
WO2008027837A3 (en) | Small molecule potentiator of hormonal therapy for breast cancer | |
IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
WO2012006589A3 (en) | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling | |
MX2012004258A (es) | Inhibidores de la tirosina quinasa de bruton. | |
MX349787B (es) | Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido. | |
EP1991701A4 (en) | COMPOSITIONS, KITS, AND METHODS FOR IDENTIFYING, EVALUATING, PREVENTING, AND TREATING CANCER | |
TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
WO2007051065A3 (en) | Compositions and treatments for inhibiting kinase and/or hmg-coa reductase | |
WO2009064444A9 (en) | Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents | |
IL182423A0 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
WO2007011962A3 (en) | Treatment of cancer | |
MX2007009807A (es) | Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento. | |
MX2019005150A (es) | Inhibidores de la tirosina-cinasa de bruton. | |
WO2006089087A9 (en) | Compositions, kits and methods for identification, assessment, prevention and therapy of cancer | |
SG155163A1 (en) | Pharmacokinetically improved compounds | |
WO2008073899A3 (en) | Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis | |
WO2007064945A3 (en) | Cancer therapies and pharmaceutical compositions used therein | |
NO20072558L (no) | Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav | |
MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
WO2008030883A3 (en) | Treatment of cancer | |
WO2006028655A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
WO2006015079A3 (en) | Erm family binding agents and their use in diagnosis and treatment of proliferative conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |